News Conference News AHA 2016 Racial Differences in How Patients Perceive CVD Risk Should Spur Rethink in Management Yael L. Maxwell November 16, 2016
News Daily News High-Intensity Statin Therapy Offers Survival Benefit Over Moderate-Intensity Statins in CVD Patients Michael O'Riordan November 10, 2016
News Daily News FH Screening Started at Time of Childhood Immunization Feasible and Effective Michael O'Riordan October 28, 2016
News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016
News Daily News Many Guidelines, Mixed Consensus: Different CVD Risk Guidelines Cause Confusion in Practice Michael O'Riordan September 16, 2016
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Daily News Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy Michael O'Riordan August 23, 2016
News Daily News The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say Shelley Wood July 19, 2016
News Daily News Sitting Pretty: Only Prolonged Sedentary Time Linked With Incident CVD Risk Michael O'Riordan July 15, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News Statins Possibly Protect Against Death, CV Events in Asymptomatic PAD Patients Caitlin E. Cox February 08, 2016